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Introduction 
Malignant brain tumors account for approximately 1% of all cancers. Based on 
Central Brain Registry of the United States (CBTRUS) statistics, the incidence rate of all 
primary, benign and malignant brain tumors is 14.0 cases per 100,000 person-years and 
7.7 cases per 100,000 person-years for malignant brain tumors (1). Several studies have 
measured the QOL of patients with malignant brain tumors, which is an important 
component of treatment since malignant brain tumors greatly impact physical and 
cognitive functioning (2-6). Using semi-structured interviews and two focus groups with 
patients with all types of brain tumors and their family members, Fox and Lantz (1998) 
identified common themes that emerged from survivors and family members regarding 
QOL (2). Themes included difficulty in coping with changes in physical and cognitive 
functioning, loss of self, the impact on the patient and the family, making the best 
decision regarding treatment when faced with numerous options, and how the meaning of 
quality of life changed between individuals. In spite of these findings, rehabilitation is 
rarely recommended and discussions of quality of life are initiated only after all treatment 
options have been exhausted. Little is known about the patient and caregiver perceptions 
on the impact of cognitive-linguistic decline on quality of life. 
 
Method 
Twenty individuals with malignant gliomas were recruited as part of a larger 
study on QOL. Participants met the following eligibility criteria: age 18 or older, no 
tumor recurrence or progression after initial diagnosis, life expectancy ≥ 3 months, 
Karnofsky Performance Status (KPS) score ≥ 70.  
Participants with brain tumors completed two quality of life measures: the 
Functional Assessment of Cancer Therapy Scale-Brain (FACT-BR [7]) and the Quality 
of life Scale/Cancer Patient Cancer Survivor (QOL-CS). The FACT-Br is composed of 
50 questions exploring physical, emotional, social/family, and functional well-being 
using a 5-point Likert scale. QOLCS is a forty one-item ordinal scale that measures the 
QOL of a cancer patient. Items representing the four domains of QOL include physical 
well-being, psychological well-being, social well-being, and spiritual well-being.  
Two research team members facilitated a focus group attended by five individuals 
with brain tumors. A Focus Group Interview Guide was developed to guide the 
discussion and insure that the four QOL domains (physical, psychological, social, and 
spiritual) were addressed during the discussion. Open-ended questions were used to elicit 
information and encourage dialogue between group members. The focus group lasted 
approximately 90 minutes and was tape-recorded for later transcription and analysis.  
Statements regarding cognitive-linguistic functioning were coded for the impact 
(increasing or reducing) on QOL. 
 
Results 
FACT-Br:  Average responses to items in the Additional Concerns subscale 
revealed many negative outcomes associated with the psychological, cognitive, and 
physical effects of brain tumors. Of particular concern were increased frustration, 
impaired concentration, impaired memory, impaired communication, difficulty 
expressing thoughts, and reduced independence (mean scores ranged from 2.44-2.74). 
Positive influences were associated with a lack of certain symptoms (e.g. good outcomes 
associated with hearing, coordination, sensation, seizures, ability to read) and continued 
independence with self-care (mean scores ranged from 3.32-3.89). 
QOLCS: The QOLCS contained only one question related to cognitive linguistic 
functioning.  The average response to “Concentration and Memory” was on the better 
outcome end of the continuum.  
Patient focus group: The psychological domain was more evenly divided 
between comments that indicate a positive quality of life and those that indicate a more 
negative one and revealed critical themes evident in the discourse of the brain tumor 
survivors. Education and information was a recurrent theme. Patients expressed anger 
and frustration over lack of information from medical personnel, particularly about 
coping with cognitive and physical symptoms associated with brain tumor. Patients 
reported educating themselves to better cope with the effects of the brain tumor. The 
cognitive changes associated with brain tumor had a negative impact on quality of life. 
Patients reported frustration with impaired memory, concentration, executive function, 
and language; particularly difficulty in coping with these changes. 
I went to the doctors and I was telling him that I feel like 
I’m not. I have the words in my head but I can’t get them 
out. And I’m thinking, am I trying to talk too fast? And he 
goes, well do you know what you want to say? And I said 
yeah, I know, it’s in my head. I know what I want to say. 
But when I try to say it, it doesn’t come out right. He just 
didn’t say anything. He said, I’ll see you in another year.  
Patients expressed anxiety, frustration, stress, fear, grief, worry, and an overall 
sense that life activities were “harder.”  Additional analysis will be conducted to measure 
the percentage of statements related to cognitive-linguistic disorders and the impact on 
quality of life.   
 
Discussion 
Cognitive-linguistic deficits are clearly a concern for individuals dealing with 
brain tumors and the consequences of treatment.  Some QOL measures may 
underestimate the impact on these symptoms on QOL. Speech-language pathologists can 
provide linguistic and functional treatments that can improve quality of life.  
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Table 1. Average response of patient group on FACT-Br Additional Concerns subsection  
 
Additional Concerns-Brain Tumor    
Frustration 1.95 2 1.58 
Bother by reduced concentration 2 2 1.53 
Independence 2.11 2 1.29 
Memory 2.44 3 1.04 
Difficulty expressing thoughts 2.47 3 1.54 
Able to find words 2.63 3 1.21 
Able to concentrate 2.74 3 1.15 
Afraid of seizures 2.74 3 1.56 
Trouble seeing 2.74 3 1.28 
Able to drive 2.74 4 1.76 
Headaches 2.79 3 1.4 
Bothered by change in personality 2.84 3 1.3 
Responsibility 3 3 0.88 
Able to put thoughts together 3 3 0.91 
Able to write 3 3 1.16 
Weakness in extremities 3 3 1.33 
Able to read 3.16 3 0.96 
Trouble hearing 3.21 4 1.32 
Trouble with coordination 3.32 4 1.2 
Able to put thoughts into action 3.47 4 0.7 
Impaired sensation 3.63 4 1.01 
Seizures 3.74 4 0.65 
Need help for self-care 3.89 4 0.46 
 Additional Concerns Total 2.90 3.17 1.18 
 
Scale: 0= not at all to 4= very much 
 
Table 2: Average response of patient group on Psychological Well-Being Subsection of 
the Quality of Life Cancer Survivor (QOLCS) 
 
Psychological Well Being 
Initial diagnosis distress 2.63 2 3.32
Cancer treatment distress 3.84 3 3.55
Fear of recurrent cancer 4.1 3.5 3.34
Control 4.95 4.5 3.56
Anxiety 5 5 3.40
Fear of second cancer 5 4.5 3.70
Appearance 5.05 5 3.30
Self-Concept 5.4 6 3.28
Usefulness 5.5 5 3.12
Fear of cancer spreading 5.5 5.5 3.79
Depression 5.6 6.5 3.12
Coping 5.75 6 3.26
Concentration/Memory 6 8 3.29
Happiness 6.15 5.5 2.94
Satisfaction 6.15 6.5 3.18
Fear of future tests 6.15 7 3.96
Time since treatment distress 6.44 7 2.94
Quality of life single item 6.75 6 2.53
Total Psychological subscale 5.34 5.56 2.13
 
Scale: 0= worst outcome or negative outcome to 10= best outcome or positive influence.  
 
 
